Marshall Wace
BPMC

Marshall Wace’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.09M Buy
31,900
+21,300
+201% +$2.73M ﹤0.01% 1143
2025
Q1
$938K Sell
10,600
-151,282
-93% -$13.4M ﹤0.01% 1704
2024
Q4
$14.1M Sell
161,882
-171,885
-51% -$15M 0.02% 616
2024
Q3
$30.9M Sell
333,767
-17,989
-5% -$1.66M 0.04% 348
2024
Q2
$37.9M Buy
351,756
+121,464
+53% +$13.1M 0.05% 301
2024
Q1
$21.8M Buy
+230,292
New +$21.8M 0.03% 425
2023
Q1
Sell
-529,456
Closed -$23.2M 2161
2022
Q4
$23.2M Buy
+529,456
New +$23.2M 0.05% 353
2022
Q2
Sell
-186,600
Closed -$11.9M 2713
2022
Q1
$11.9M Sell
186,600
-764,082
-80% -$48.8M 0.02% 716
2021
Q4
$102M Buy
950,682
+923,577
+3,407% +$98.9M 0.19% 95
2021
Q3
$2.79M Sell
27,105
-11,981
-31% -$1.23M 0.01% 1070
2021
Q2
$3.44M Buy
+39,086
New +$3.44M 0.02% 898
2021
Q1
Sell
-3,642
Closed -$408K 2135
2020
Q4
$408K Sell
3,642
-257,260
-99% -$28.8M ﹤0.01% 1422
2020
Q3
$24.2M Buy
260,902
+238,042
+1,041% +$22.1M 0.15% 117
2020
Q2
$1.78M Sell
22,860
-188,146
-89% -$14.7M 0.01% 807
2020
Q1
$12.3M Buy
211,006
+204,103
+2,957% +$11.9M 0.12% 170
2019
Q4
$553K Buy
+6,903
New +$553K ﹤0.01% 1090
2019
Q1
Sell
-8,635
Closed -$466K 1711
2018
Q4
$466K Sell
8,635
-139,699
-94% -$7.54M ﹤0.01% 1118
2018
Q3
$11.6M Buy
+148,334
New +$11.6M 0.1% 275
2017
Q1
Sell
-30,302
Closed -$850K 355
2016
Q4
$850K Buy
+30,302
New +$850K 0.01% 774